10x Genomics has agreed to acquire Scale Biosciences, a specialist [...]

New research from Pioneer Group, in collaboration with Beauhurst, reveals [...]

Boston-based Strand Therapeutics has raised $153 million in a Series [...]

DEBRA Research, a non-profit focused on Epidermolysis bullosa (EB), has [...]

Advanced Sterilization Products (ASP) has introduced a new steam biological [...]

Advarra, known for regulatory reviews and clinical research technology, has [...]

ScaleReady has awarded a $100,000 G-Rex grant to Sidra Medicine, [...]

A genetically targeted approach to depression treatment has shown promising [...]

Revolo Biotherapeutics says it is accelerating plans to bring a [...]

James Anderson is the Chair of the INTREPID Alliance and the Executive Director of Global Health at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), a leading global organization representing pharmaceutical companies. In his role at IFPMA, James spearheads efforts to address critical global health challenges, including antimicrobial resistance, pandemic preparedness, and non-communicable diseases.